Rights and permissions
About this article
Cite this article
Cancer drugs: time to rethink clinical endpoints?. Inpharma Wkly. 1342, 4 (2002). https://doi.org/10.2165/00128413-200213420-00006
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200213420-00006